Skip to main content
OpenTrials
Completed

NCT Number: NCT05596903

Effect of Eye Movement Desensitization and Reprocessing Therapy 2.0 Online Group Protocol

In this study, it will be investigated the efficacy of Eye Movement Desensitization and Reprocessing Therapy 2.0 Online Group Protocol on post-traumatic symptoms compared to control group. Therefore, the randomized control trial is based on Eye Movement Desensitization and Reprocessing Therapy 2.0 group as an intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Academy of Therapeutic Sciences

Istanbul, Turkey (Türkiye)

About this study

Eye Movement Desensitization and Reprocessing Therapy is an evidence-based psychotherapy approach, and it is proven as efficient in primarily post-traumatic symptom disorder. EMDR 2.0 is a new approach which is used for the cases that are not answering the standard EMDR protocols. According to the recent studies, both EMDR and EMDR 2.0 show a greater decrease in emotionality and vividness in similar time based on session numbers (Matthijssen, 2021). Also, it is found that EMDR 2.0 requires lower set numbers (shorter sessions) compared to EMDR.

In this study, it will be investigated the efficacy of EMDR 2.0 Online Group Protocol on post-traumatic symptoms compared to control group. Therefore, the randomized control trial is based on EMDR 2.0 group as an intervention. Compared to previous EMDR 2.0 individual settings, this study is based on a group protocol made by our team. This group protocol has been tested in a pilot study on volunteer mental health professionals. The results of this pilot study showed that EMDR 2.0 group protocol was successful, and investigators decided to begin the randomized control trial research.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being older than 18
  • Having a traffic accident between 6 months and 10 years
  • Having necessary knowledge on using relevant technological devices

Exclusion criteria

  • Having mental deterioration after the accident
  • Having a lower score of 7 on Adverse Childhood Experiences (ACEs)
  • Having pre-existing psychotic disorder

Treatment and study plan

EMDR 2.0 group protocol

Other

EMDR 2.0 group protocol

Mhgap stress module

Other

Mhgap stress module

Primary outcomes

  1. The Depression, Anxiety and Stress Scale - 21 Items (DASS-21)

    Time frame: 1-week and 1-month follow-up

    Depression, stress and anxiety scores will significantly change. Scores for depression, anxiety and stress are calculated by summing the scores. The scores are between 0-3, and more scores mean worse results.

    for the relevant items

  2. Impact of Events Scale Revised (IES-R)

    Time frame: 1-week and 1-month follow-up

    Intrusion and hyperarousal scores will significantly change. The maximum mean score on each of the three subscales is '4', therefore the maximum 'total mean' IES- R score is 12. Lower scores are better.

Sponsors and collaborators

Lead sponsor

Academy of Therapeutic Sciences, Turkey

Other

Registry information

Official study title

Effect of Eye Movement Desensitization and Reprocessing Therapy 2.0 Online Group Protocol on Traumatic Experiences Based on Traffic Accident: A Randomized Controlled Trial

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Oct 27, 2022
Registry last updated
May 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.